Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China

Fig. 4

Probabilistic sensitivity analyses in rural and urban. a Probabilistic sensitivity analyses with discounted in rural. b Probabilistic sensitivity analyses with undiscounted in rural. c Probabilistic sensitivity analyses with discounted in urban. d Probabilistic sensitivity analyses with undiscounted in urban. (Note: X-axis represents the incremental QALYs and y-axis represents the incremental costs. Each blue dot on the graph represents the relative discounted/undiscounted ICER of one out of the 10,000 simulations and the red dot represents the average value. Quadrant I represents comparing with screening only, vaccine and screening would gain more QALYs with the costs increasing. Quadrant II represents comparing with screening only, vaccine and screening would gain more QALYs with the costs decreasing. Quadrant III represents comparing with screening only, vaccine and screening would lose more QALYs with the costs decreasing. Quadrant IV represents comparing with screening only, vaccine and screening would lose more QALYs with the costs increasing. Quadrant II means vaccine and screening would be more cost-effective compared with screening only. Quadrant IV means screening only would be more cost-effective compared with vaccine and screening)

Back to article page